HeartSciences insider files Form 144 for $15.7k share sale

Rhea-AI Filing Summary

HeartSciences Inc. (HSCSW) – Form 144 filing

The notice covers a planned sale of 4,416 common shares through The Charles Schwab Corporation, expected on 29 Jul 2025 on NASDAQ. Based on the disclosed aggregate market value of $15,720.96, the implied price is roughly $3.56 per share. The stock was originally purchased on 08 Dec 2014 from the issuer. No other sales by the filer have occurred in the past three months, and the filer affirms no knowledge of undisclosed adverse information.

The issuer reports 1,934,280 shares outstanding, so the proposed sale equals about 0.23 % of outstanding stock. The form supplies no name or relationship of the seller, indicating only routine compliance with Rule 144 rather than a strategic shift. No financial performance data, guidance changes, or operational updates accompany the filing.

Insights

Securities Analyst

TL;DR – Small Rule 144 sale (0.23 % O/S); immaterial for valuation, neutral signal.

This filing simply registers a prospective disposition of 4,416 restricted shares, worth about $15.7 k, by an undisclosed holder. For a micro-cap with 1.93 m shares outstanding, the transaction is de minimis and does not alter governance, liquidity, or capital structure. Absence of additional insider selling over the past quarter and the routine nature of Rule 144 suggest no directional clue regarding fundamentals. I view the event as non-impactful for portfolio decisions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	THE CHARLES SCHWAB CORPORATION 3000 Schwab Way Westlake TX 76262	4416	15720.96	1934280	07/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	12/08/2014	PURCHASE	ISSUER			4416	12/08/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many HeartSciences (HSCSW) shares are being registered for sale?

4,416 common shares are listed in the Form 144 filing.

What is the aggregate market value of the proposed sale?

The filing states an aggregate value of $15,720.96.

When is the approximate sale date for the HSCSW shares?

The filer indicates an approximate sale date of 07/29/2025.

What percentage of HeartSciences’ outstanding shares does this sale represent?

With 1,934,280 shares outstanding, the sale equals about 0.23 % of shares outstanding.

Were any other securities sold by the filer in the past three months?

No. The section ‘Securities Sold During The Past 3 Months’ reports “Nothing to Report.”

Why is a Form 144 required for this transaction?

Rule 144 mandates notice when restricted or control securities are to be sold, ensuring advance public disclosure.